We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$36B
AUM Growth
+$4.16B
(+13%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
37.04%
Holding
1,767
New
125
Increased
1,085
Reduced
387
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$315M |
| 2 |
Apple
AAPL
|
+$187M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Meta Platforms (Facebook)
META
|
+$118M |
| 5 |
Tesla
TSLA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$61.1M |
| 2 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$51.8M |
| 3 |
Invesco Aerospace & Defense ETF
PPA
|
+$38.3M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$37.5M |
| 5 |
Invesco S&P 500 Momentum ETF
SPMO
|
+$36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.91% |
| 2 | Communication Services | 10.86% |
| 3 | Consumer Discretionary | 9.43% |
| 4 | Healthcare | 6.67% |
| 5 | Financials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Sunstone Hotel Investors
SHO
$2.02B
| $47.1K | ﹤0.01% |
5,274
+1,135
| +27% | +$10.4K |
|
1402
AGCO
AGCO
$6.96B
| $46.6K | ﹤0.01% |
+447
| New | +$47.5K |
|
1403
Ecopetrol
EC
$35.4B
| $46.6K | ﹤0.01% |
4,648
+243
| +6% | +$2.32K |
|
|
DAWN
1404
DELISTED
Day One Biopharmaceuticals
DAWN
| $46.5K | ﹤0.01% |
4,989
+1,029
| +26% | +$8.6K |
|
|
LTC
1405
LTC Properties
LTC
$2.1B
| $46.3K | ﹤0.01% |
1,346
+340
| +34% | +$12K |
|
1406
Richtech Robotics
RR
$385M
| $46.2K | ﹤0.01% |
14,308
+1,182
| +9% | +$5.23K |
|
|
ALMS
1407
Alumis Inc
ALMS
$3.11B
| $46.1K | ﹤0.01% |
4,724
+979
| +26% | +$6.83K |
|
1408
Theravance Biopharma
TBPH
$878M
| $46.1K | ﹤0.01% |
2,462
+515
| +26% | +$8.54K |
|
1409
Royal Gold
RGLD
$19.1B
| $45.8K | ﹤0.01% |
+206
| New | +$40.9K |
|
1410
Credicorp
BAP
$29.8B
| $45.6K | ﹤0.01% |
+159
| New | +$42.1K |
|
|
RAPT
1411
DELISTED
RAPT Therapeutics
RAPT
| $45.6K | ﹤0.01% |
+1,347
| New | +$41.8K |
|
1412
Genpact
G
$5.78B
| $45.5K | ﹤0.01% |
973
-192
| -16% | -$8.3K |
|
1413
First Citizens BancShares
FCNCA
$25.6B
| $45.1K | ﹤0.01% |
21
+2
| +11% | +$3.77K |
|
1414
Arbutus Biopharma
ABUS
$906M
| $45K | ﹤0.01% |
9,346
+1,935
| +26% | +$8.7K |
|
|
BCAX
1415
Bicara Therapeutics
BCAX
$1.56B
| $44.8K | ﹤0.01% |
+2,662
| New | +$45.5K |
|
1416
Lantheus
LNTH
$6.59B
| $44.8K | ﹤0.01% |
673
-8,208
| -92% | -$478K |
|
1417
monday.com
MNDY
$3.99B
| $44.7K | ﹤0.01% |
303
-92
| -23% | -$15.5K |
|
1418
Bath & Body Works
BBWI
$3.76B
| $44.7K | ﹤0.01% |
2,224
+36
| +2% | +$795 |
|
1419
CorMedix
CRMD
$639M
| $44.5K | ﹤0.01% |
3,829
+943
| +33% | +$10.4K |
|
1420
Enliven Therapeutics
ELVN
$4.25B
| $44.4K | ﹤0.01% |
2,884
+594
| +26% | +$11.8K |
|
1421
Woodward
WWD
$21.2B
| $44.1K | ﹤0.01% |
146
-5
| -3% | -$1.38K |
|
1422
Kura Oncology
KURA
$896M
| $43.9K | ﹤0.01% |
4,228
+872
| +26% | +$9.15K |
|
|
ALEX
1423
DELISTED
Alexander & Baldwin
ALEX
| $43.9K | ﹤0.01% |
2,125
+532
| +33% | +$9.24K |
|
1424
Mattel
MAT
$4.25B
| $43.8K | ﹤0.01% |
2,209
-206
| -9% | -$3.98K |
|
|
EXAS
1425
DELISTED
Exact Sciences
EXAS
| $43.7K | ﹤0.01% |
+430
| New | +$34.5K |
|
Similar funds
BC
Mirae Asset Global Investments's Q4 2025 Portfolio in Review
As of Q4 2025, Mirae Asset Global Investments held 1,767 positions worth $36B, up 13% from $31.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mirae Asset Global Investments deployed $3.25B of net new capital in Q4 2025, opening 125 new positions and adding to 1,085 existing holdings. Its largest new stake was iShares Biotechnology ETF: 195,308 shares worth $33M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $61.1M trimmed.
- Mirae Asset Global Investments's largest Q4 2025 buy was iShares Biotechnology ETF: 195,308 shares worth $33M.
- Mirae Asset Global Investments added most to NVIDIA in Q4 2025, an estimated $315M increase.
- Mirae Asset Global Investments's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $61.1M.
- Mirae Asset Global Investments fully exited Invesco Aerospace & Defense ETF in Q4 2025, selling an estimated $38.3M.
- Mirae Asset Global Investments's ten largest holdings make up 37% of its $36B portfolio in Q4 2025.
- Mirae Asset Global Investments opened 125 new positions and closed 124 in Q4 2025.
- Mirae Asset Global Investments's portfolio value rose 13% quarter-over-quarter to $36B.
Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.